María Rebeca Toledo-Cardenas

Dr. María Rebeca Toledo-Cardenas

Instituto de Investigaciones Cerebrales, Universidad Veracruzana, Xalapa, Veracruz, Mexico
orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 December 2022 in NeuroSci
Verified
Journal Article
Open access
PDF file
SLSandra Yasbeth Lara
Sandra Yasbeth Lara
ÁFÁngel de Jesús Laureani Fierro
Ángel de Jesús Laureani Fierro
GAGonzalo Aranda-Abreu
Gonzalo Aranda-Abreu
María Rebeca Toledo-CardenasMaría Rebeca Toledo-Cardenas
María Rebeca Toledo-Cardenas
Luis I. GarcíaLuis I. García
Luis I. García
CECESAR ANTONIO PEREZ ESTUDILLO
CESAR ANTONIO PEREZ ESTUDILLO
For years, the biochemical processes that are triggered by harmful and non-harmful stimuli at the central nervous system level have been extensively studied by the scientific community through numerous techniques and animal models. For example, one of these techniques is the use of immediate expression genes, which is a useful, accessible, and reliable method for observing and quantifying cell activation. It has been shown that both the c-fos gene and its protein c-Fos have rapid activation after stimulus, with the length of time that they remain active depending on the type of stimulus and the activation time depending on the stimulus and the structure studied. Fos requires the participation of other genes (such as c-jun) for its expression (during hetero-dimer forming). c-Fos dimerizes with c-Jun protein to form factor AP-1, which promotes the transcription of various genes. The production and removal of c-Fos is part of cellular homeostasis, but its overexpression results in increased cell proliferation. Although Fos has been used as a marker of cellular activity since the 1990s, which molecular mechanism participates in the regulation of the expression of this protein is still unknown because the gene and the protein are not specific to neurons or glial cells. For these reasons, this work has the objective of gathering information about this protein and its use in neuroscience.

1 March 2016 in Physiology & Behavior
Verified
Journal Article
Closed access
MPMiguel Perez-Pouchoulen
Miguel Perez-Pouchoulen
María Rebeca Toledo-CardenasMaría Rebeca Toledo-Cardenas
María Rebeca Toledo-Cardenas
Luis I. GarcíaLuis I. García
Luis I. García
CECESAR ANTONIO PEREZ ESTUDILLO
CESAR ANTONIO PEREZ ESTUDILLO
Genaro Alfonso Coria-AvilaGenaro Alfonso Coria-Avila
Genaro Alfonso Coria-Avila
Jorge ManzoJorge Manzo
Jorge Manzo

19 December 2022 in Animals
Verified
Journal Article
Open access
PDF file
Genaro Alfonso Coria-AvilaGenaro Alfonso Coria-Avila
Genaro Alfonso Coria-Avila
Deissy Herrera-CovarrubiasDeissy Herrera-Covarrubias
Deissy Herrera-Covarrubias
Luis I. GarcíaLuis I. García
Luis I. García
María Rebeca Toledo-CardenasMaría Rebeca Toledo-Cardenas
María Rebeca Toledo-Cardenas
MHMaria Elena Hernandez-Aguilar
Maria Elena Hernandez-Aguilar
Jorge ManzoJorge Manzo
Jorge Manzo
Among the different species of mammals, the expression of maternal behavior varies considerably, although the end points of nurturance and protection are the same. Females may display passive or active responses of acceptance, recognition, rejection/fear, or motivation to care for the offspring. Each type of response may indicate different levels of neural activation. Different natural stimuli can trigger the expression of maternal and paternal behavior in both pregnant or virgin females and males, such as hormone priming during pregnancy, vagino-cervical stimulation during parturition, mating, exposure to pups, previous experience, or environmental enrichment. Herein, we discuss how the olfactory pathways and the interconnections of the medial preoptic area (mPOA) with structures such as nucleus accumbens, ventral tegmental area, amygdala, and bed nucleus of stria terminalis mediate maternal behavior. We also discuss how the triggering stimuli activate oxytocin, vasopressin, dopamine, galanin, and opioids in neurocircuitries that mediate acceptance, recognition, maternal motivation, and rejection/fear.

14 July 2016 in International Journal of Developmental Neuroscience
Verified
Journal Article
Closed access
MPMiguel Perez‐Pouchoulen
Miguel Perez‐Pouchoulen
MMMarta Miquel
Marta Miquel
PSPaul Saft
Paul Saft
BBBrenda Brug
Brenda Brug
María Rebeca Toledo-CardenasMaría Rebeca Toledo-Cardenas
María Rebeca Toledo-Cardenas
Jorge ManzoJorge Manzo
Jorge Manzo

13 May 2025 in Neurology International
Verified
Journal Article
Open access
PDF file
GAGonzalo Aranda-Abreu
Gonzalo Aranda-Abreu
FRFausto Rojas-Durán
Fausto Rojas-Durán
MHMaria Elena Hernandez-Aguilar
Maria Elena Hernandez-Aguilar
Deissy Herrera-CovarrubiasDeissy Herrera-Covarrubias
Deissy Herrera-Covarrubias
Luis I. GarcíaLuis I. García
Luis I. García
Lizbeth Chi-CastañedaLizbeth Chi-Castañeda
Lizbeth Chi-Castañeda
Tau protein plays a pivotal role in maintaining neuronal structure and function through its regulation of microtubule stability and neuronal polarity. Encoded by the MAPT gene, Tau exists in multiple isoforms due to alternative mRNA splicing, with differential expression in the central and peripheral nervous systems. In healthy neurons, tau mRNA is selectively localized and translated in axons, a process tightly regulated by untranslated regions (UTRs) and RNA-binding proteins such as HuD and FMRP. Pathologically, Tau undergoes hyperphosphorylation, misfolding, and aggregation, which contribute to neurodegeneration in a range of disorders collectively known as tauopathies. Alzheimer’s disease (AD) is the most prevalent tauopathy, where abnormal Tau accumulation in the temporal and frontal lobes correlates with cognitive decline and behavioral symptoms. Other tauopathies, including Progressive Supranuclear Palsy (PSP), Corticobasal Degeneration (CBD), Frontotemporal Dementia with Parkinsonism (FTDP-17), and Pick’s disease, are distinguished by the predominance of specific Tau isoforms (3R or 4R), cellular distribution, and affected brain regions. Notably, astroglial tauopathies highlight the pathological role of Tau accumulation in glial cells, expanding the understanding of neurodegeneration beyond neurons. Despite advances in imaging biomarkers (e.g., Tau-PET) and molecular diagnostics, effective disease-modifying therapies for tauopathies remain elusive. Ongoing research targets Tau through immunotherapies, splicing modulators, kinase inhibitors, and antisense oligonucleotides, aiming to mitigate Tau pathology and its deleterious effects. Understanding the multifaceted roles of Tau in neuronal and glial contexts is critical for developing future therapeutic strategies against tauopathies.

28 December 2023 in NeuroSci
Verified
Journal Article
Open access
PDF file
HLHugo Libreros
Hugo Libreros
Jorge ManzoJorge Manzo
Jorge Manzo
FRFausto Rojas-Durán
Fausto Rojas-Durán
GAGonzalo Aranda-Abreu
Gonzalo Aranda-Abreu
Luis I. GarcíaLuis I. García
Luis I. García
MHMaria Elena Hernandez-Aguilar
Maria Elena Hernandez-Aguilar
The twelve cranial nerves play a crucial role in the nervous system, orchestrating a myriad of functions vital for our everyday life. These nerves are each specialized for particular tasks. Cranial nerve I, known as the olfactory nerve, is responsible for our sense of smell, allowing us to perceive and distinguish various scents. Cranial nerve II, or the optic nerve, is dedicated to vision, transmitting visual information from the eyes to the brain. Eye movements are governed by cranial nerves III, IV, and VI, ensuring our ability to track objects and focus. Cranial nerve V controls facial sensations and jaw movements, while cranial nerve VII, the facial nerve, facilitates facial expressions and taste perception. Cranial nerve VIII, or the vestibulocochlear nerve, plays a critical role in hearing and balance. Cranial nerve IX, the glossopharyngeal nerve, affects throat sensations and taste perception. Cranial nerve X, the vagus nerve, is a far-reaching nerve, influencing numerous internal organs, such as the heart, lungs, and digestive system. Cranial nerve XI, the accessory nerve, is responsible for neck muscle control, contributing to head movements. Finally, cranial nerve XII, the hypoglossal nerve, manages tongue movements, essential for speaking, swallowing, and breathing. Understanding these cranial nerves is fundamental in comprehending the intricate workings of our nervous system and the functions that sustain our daily lives.